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Caspofungin vs. Caspofungin Combined with 
Liposomal Amphotericin B for the Treatment of 
Cerebral Aspergillosis in a Nursing Rat Model 
100 
A Negative Procalcitonin (PCT) Test as an 
Indicator of Fever of Non-Bacterial Etiology in 
Neutropenic Cancer Patients with FUO 
R. Strahm, S.L. Leib, J. Kummer, S. Zimmer[i*. 
Institute [or Infectious Diseases University of 
Bern, Switzerland 
Background: Cerebral aspergi[[osis is associated 
with an unacceptably high mortality despite anti- 
funga[ treatment. 
Objectives: To compare the efficacy of caspofun- 
gin combined with [iposoma[ amphotericin B vs. 
caspofungin alone for the treatment of cerebral 
aspergi[[osis in immunocompetent nursing rats. 
Methods: ELeven-day-oLd non-immunosuppressed 
Wistar Wl rats were infected by intracisterna[ in- 
jection of 10pL of a conidia[ suspension of As- 
pergi[[us fumigatus. Treatment started 18h after 
infection and was given for 10 days. Regimens 
were caspofungin 1 mg/kg/d i.p. (n=20) and [i- 
posoma[ amphotericin B 5 mg/kg/d + caspofungin 
lmg/kg/d i.p. (n= 21).lnfected controls (n=14) 
were given NaC[ 0.9% or glucose 5% i.p. 
Results: ControLs consistently showed symptoms 
of cerebra[ AsperBillus infection. Their mean sur- 
vival time was 4.4 days. Treatment significantly 
increased survival time to 10.5 and 9.3 days for 
caspofungin alone and caspofungin combined with 
amphotericin B, respectively. The difference be- 
tween treatment regimens was not significant. CNS 
fungus burden determined by culture of corti- 
cal homogenates declined over time; interestingLy, 
there was no significant difference between con- 
trots and treated animals. Two animals in each 
treatment group had sterile brain cultures. Fun- 
ga[ dissemination determined by culture of kidney 
homogenates was found in 7/14 controls, 0/20 an- 
imals treated with caspofungin, and 1/21 animals 
of the combination group. 
Conclusion: Caspofungin atone and in combina- 
tion with [iposoma[ amphotericin B significantly 
increases survival time in a Lethal mode[ of cerebra[ 
aspergi[[osis. RemarkabLy, CNS fungus burden did 
not differ between controls and treated animals. 
The hypothesis that antifunga[ treatment may re- 
sult in a decreased inflammatory reaction is being 
further investigated. 
O.J. Robinson, T. Ca[andra, E Batty, M. Kaup, 
W. Beier, O. Marchetti*. Centre Hospitalier 
Universitaire Vaudois (CHUV), Lausanne, 
Switzerland 
Objectives: FUO accounts for 25-50% of at( febrile 
episodes (FE) in neutropenic cancer patients and 
may reflect the presence either of a non-infectious 
fever or of an occult infection. Given that infec- 
tion cannot be ruled out, most patients with fever 
of unknown origin (FUO) are treated with broad- 
spectrum antibiotics for extended periods of time 
(IDSA, CID, 2002). Identification of patients with 
fever of non-bacteria( etiology, in whom antibi- 
otics could be stopped rapidly (i.e. within 48-72 h 
of fever onset), would help to reduce treatment 
costs, adverse events and minimize the risk of 
development of resistance. In children with menin- 
gitis and in criticaLLy it( patients, PCT has been 
shown to distinguish bacteria[ from viral infections 
or from inflammatory diseases. The aim of the 
present study was to evaluate the utility of PCT 
for the management of neutropenic FUO. 
Methods: 171 FE in 125 consecutive neutropenic 
patients undergoing intensive chemotherapy for 
hematoLogicaL malignancies were studied prospec- 
tively over 18 months. FE were classified as micro- 
bioLogicaLLy (MDI) or cLinicaLLy (CDI) documented in- 
fections and FUO according to standard definitions 
(ICHS, JID, 1990). PLasma concentrations of PCT 
(KRYPTOR-PCT, BRAHMS, Germany) were measured 
twice weekly in the absence of fever and daily 
within 4 days of a FE. Test was considered to be 
negative if PCT was <0.5 pg/[. 
Results: 46/171 FE (27%) were classified as FUO. 
Among these, PCT remained negative in 32 (median 
0.2ng/m[) and became positive within 72h in 14 
(median 0.7) (p < 0.001) reaching LeveLs compara- 
ble to those measured in MDI (median 0.8) and 
CDI (median 0.5). Apart from PCT LeveLs at day 3, 
these two subgroups of FUO patients were cLini- 
caLLy indistinguishable: peak temperature (38.5 vs. 
38.6oc), time to defervescence (2 days, range 1-9 
vs. 2 days, range 1-6) and duration of antibiotic 
therapy (8 vs. 7 days). Thus, PCT was the only 
parameter capable of distinguishing FUO patients 
LikeLy to have fever of non-bacteria( etiology (Low 
PCT) from those LikeLy to have an occult bacteria[ 
infection (eLevated PCT). 
Conclusions: A negative PCT (<0.5 pg/[) within 72 h 
after onset of fever in neutropenic cancer patients 
Infections in Cancer and Hematotogica[ Matignancies $57 
with FUO is an indicator of fever of non-bacterial 
etiology suggesting that empirical antibiotic ther- 
apy might be discontinued in these patients. This 
strategy should be tested prospectively. 
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Candida Lusitaniae Blood Stream Infection 
in King Faisal Specialist Hospital Et Research 
Centre, Riyadh, Saudi Arabia 
A. Al Aidaroos, I. Bin-Hussain*, D. Al Shahrani. 
King Faisal Specialist Hospital Et Research Centre, 
Riyadh, Saudi Arabia 
Background: Candida lusitaniae is a rare non- 
albicans Candida spp. which is increasingly recog- 
nized as an emerging nosocomial pathogen partic- 
ularly in immunocompromised patients ince 1990, 
with a high mortality rate. 
Objectives: We describe the pediatric cases of 
Candida lusitaniae blood stream infection in 
KFSHEtRC over nine years to elaborate on an emerg- 
ing organism, its predisposing factors, antifungal 
susceptibility, and the clinical outcome of C. lusi- 
taniae candidemia. 
Methods: The records of the microbiology labora- 
tory at the KFSHEtRC were reviewed for the period 
01 January 1996 through 31 December 2004 to 
identify all cases of hematogenous C. lusitaniae 
candidemia. A total of 6 cases were documented 
and the medical records of all six patients were 
reviewed. 
Results: In our institution, C. lusitaniae represent 
2.6% of the total Candida species isolated from 
229 pediatric blood culture samples over 9 years 
period (1996-2004). Six cases of C. lusitaniae blood 
stream infections were isolated from 6 patients. 
Two neonates with congenital heart disease, 4 in- 
fants with CHD, FTT, Omenn's syndrome and HUS 
respectively. All of them had fungemia associated 
with broad-spectrum antibiotic therapy and cen- 
tral venous lines, 5 required intensive care (ICU) 
admission and 4 received TPN, which are all known 
to be risk factors for fungemia by other Candida 
species. In our cases, the MIC for the isolates from 
3 patients were >32ug/ml for AmB but sensitive 
to fluconazole MIC < 8 ug/ml. Five patients treated 
successfully with fluconazole. 
Conclusion: C. lusitaniae is an important cause of 
nosocomial infection among immunocompromised 
hosts. Early identification and proper susceptibil- 
ity testing is very important guidance toward the 
successful treatment. 
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Retrospective Study of Pediatric Candida Blood 
Stream Infection at KFSHRC 
A. Al Aidaroos, I. Bin-Hussain*, D. Sharani, 
M.L. Guy, H. Abdely, S. Thawadi. King Faisal 
Specialist Hospital & Research Centre, Riyadh, 
Saudi Arabia 
Background: Candida species are important blood 
stream pathogens that are being isolated with in- 
creasing frequency. Despite the availabNty of ef- 
fective antifungal therapy, the mortality rate asso- 
ciated with Candida infection remains high. 
Objective: To describe the epidemiology of can- 
didemia in the pediatric group at the King Faisal 
Speoalist HosNtal Et Research Centre (KFSHEtRC), 
in relation to underlying medical condition, predis- 
posing factors, concurrent infection antimicroNal 
agents, antifungal treatment and outcome. 
Method: Retrospective chart review of all patients 
with Candida blood stream infections age 0-14- 
years at KFSHEtRC utilizing Microbiology and Infec- 
tion Control databases for the period January 1996 
through December 2004. 
Results: Total of 229 pediatric patients with pos- 
itive blood culture for Candida spp. 91.2% were 
Saudi Et 59.3% were males. The majority of them 
(30.5%) in the hematology/oncology ward followed 
by (20%) in the pediatric intensive care unit (PICU). 
50.6% of the cases presented with fever and 27.5% 
with hypotension. Most of the patients (89.0%) had 
central venous lines which were removed after 
candidemia in 76.4% with survival of 65.1%. Other 
risk factors like total parenteral nutrition (TPN) 
recorded in 51% of the patien ts, and 61.5% received 
93 antibiotics. Dissemination of the fungal infec- 
tion occurred in 17.4% and the mortality because 
of candidemia alone is 3% and candidemia as a con- 
tributing factor for mortality in addition to other 
causes in 19%. 
Conclusion: Candida is a major cause of blood 
stream infections at KFSHEtRC, contribution to 
mortality in 22%. Candida albicans is the pre- 
dominant pathogen followed by C. tropicalis and 
C. parapsillosis. CVL is an important risk factor and 
its removal improves outcome. 
